Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection

BACKGROUND: Hepatic schistosomiasis is considered to be one of the most prevalent forms of chronic liver disease in the world due to its complication of liver fibrosis. The demonstration of the pro-fibrogenic role of angiotensin (Ang) II in chronic liver disease brought up the idea that anti-Ang II...

Descripción completa

Detalles Bibliográficos
Autores principales: Attia, Yasmeen M, Elalkamy, Essam F, Hammam, Olfat A, Mahmoud, Soheir S, El-Khatib, Aiman S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733928/
https://www.ncbi.nlm.nih.gov/pubmed/23829789
http://dx.doi.org/10.1186/1756-3305-6-199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733928/
https://www.ncbi.nlm.nih.gov/pubmed/23829789
http://dx.doi.org/10.1186/1756-3305-6-199

Ejemplares similares